Page last updated: 2024-08-17

levodopa and Striatonigral Atrophy

levodopa has been researched along with Striatonigral Atrophy in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (62.50)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Breger, LS; Cenci, MA; Fieblinger, T; Lockowandt, M; Lundberg, C; Quintino, L; Sebastianutto, I; Zanetti, L1
Döbrössy, M; Garcia, J; Göbel, G; Granata, R; Jellinger, K; Kaindlstorfer, C; Krismer, F; Stefanova, N; Wenning, GK1
Jeon, SR; Kim, YH; Shin, ES; Yoon, HH1
Langston, JW; Protell, PH; Tan, LC; Togasaki, DM1
Bioulac, B; Fernagut, PO; Ghorayeb, I; Stefanova, N; Tison, F; Wenning, GK1
Cenci, MA; Lundblad, M; Poewe, W; Stefanova, N; Tison, F; Wenning, GK1
Aubert, I; Bezard, E; Fernagut, PO; Ghorayeb, I; Poewe, W; Tison, F; Wenning, GK1
Jellinger, K; Seppi, K; Tison, F; Wenning, GK1

Other Studies

8 other study(ies) available for levodopa and Striatonigral Atrophy

ArticleYear
Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats.
    Scientific reports, 2018, 07-03, Volume: 8, Issue:1

    Topics: Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dyskinesia, Drug-Induced; Female; Levodopa; Mice; Mice, Transgenic; Neostriatum; Neurons; Parkinson Disease; Phenotype; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Striatonigral Degeneration

2018
L-dopa response pattern in a rat model of mild striatonigral degeneration.
    PloS one, 2019, Volume: 14, Issue:6

    Topics: Animals; Behavior, Animal; Corpus Striatum; Denervation; Disease Models, Animal; Levodopa; Motor Activity; Multiple System Atrophy; Quinolinic Acid; Rats; Striatonigral Degeneration

2019
A rat model of striatonigral degeneration generated by simultaneous injection of 6-hydroxydopamine into the medial forebrain bundle and quinolinic acid into the striatum.
    Journal of Korean medical science, 2014, Volume: 29, Issue:11

    Topics: Animals; Apomorphine; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Glucose; Injections, Intraperitoneal; Levodopa; Male; Medial Forebrain Bundle; Oxidopamine; Parkinson Disease; Positron-Emission Tomography; Quinolinic Acid; Rats; Rats, Wistar; Striatonigral Degeneration; Touch

2014
The hyperkinetic abnormal movements scale: a tool for measuring levodopa-induced abnormal movements in squirrel monkeys.
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Female; Hyperkinesis; Levodopa; Male; Observer Variation; Random Allocation; Reproducibility of Results; Saimiri; Sensitivity and Specificity; Striatonigral Degeneration; Surveys and Questionnaires

2002
Dystonia is predictive of subsequent altered dopaminergic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine+3-nitropropionic acid model of striatonigral degeneration in monkeys.
    Neuroscience letters, 2002, Dec-19, Volume: 335, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Dystonia; Female; Levodopa; Macaca fascicularis; Neurotoxins; Nitro Compounds; Parkinsonian Disorders; Propionates; Putamen; Striatonigral Degeneration; Substantia Nigra

2002
Effects of pulsatile L-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy).
    Neurobiology of disease, 2004, Volume: 15, Issue:3

    Topics: Animals; Antiparkinson Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesias; Forelimb; Image Processing, Computer-Assisted; Levodopa; Male; Movement Disorders; Parkinson Disease; Rats; Striatonigral Degeneration

2004
Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
    Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Brain Mapping; Corpus Striatum; Diagnosis, Differential; Disease Models, Animal; Dopamine; Levodopa; Macaca fascicularis; Male; Multiple System Atrophy; Nerve Degeneration; Neurotoxins; Nitro Compounds; Parkinson Disease, Secondary; Propionates; Striatonigral Degeneration

2000
A novel grading scale for striatonigral degeneration (multiple system atrophy).
    Journal of neural transmission (Vienna, Austria : 1996), 2002, Volume: 109, Issue:3

    Topics: Adult; Aged; Caudate Nucleus; Disease Progression; Female; Gliosis; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Neurons; Prospective Studies; Putamen; Striatonigral Degeneration; Substantia Nigra

2002